Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Publikationen
Suchbegriffe: CACO-2 CELLS - , . Treffer: 12
2016
Mercuri, A; Wu, S; Stranzinger, S; Mohr, S; Salar-Behzadi, S; Bresciani, M; Fröhlich, E
In vitro and in silico characterisation of Tacrolimus released under biorelevant conditions.
Int J Pharm. 2016; 515(1-2):271-280
Doi: 10.1016/j.ijpharm.2016.10.020
Web of Science
PubMed
FullText
FullText_MUG
Pehserl, AM; Ress, AL; Stanzer, S; Resel, M; Karbiener, M; Stadelmeyer, E; Stiegelbauer, V; Gerger, A; Mayr, C; Scheideler, M; Hutterer, GC; Bauernhofer, T; Kiesslich, T; Pichler, M
Comprehensive Analysis of miRNome Alterations in Response to Sorafenib Treatment in Colorectal Cancer Cells.
Int J Mol Sci. 2016; 17(12):
Doi: 10.3390/ijms17122011
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Ripert, G; Racedo, SM; Elie, AM; Jacquot, C; Bressollier, P; Urdaci, MC
Secreted Compounds of the Probiotic Bacillus clausii Strain O/C Inhibit the Cytotoxic Effects Induced by Clostridium difficile and Bacillus cereus Toxins.
Antimicrob Agents Chemother. 2016; 60(6):3445-3454
Doi: 10.1128/AAC.02815-15
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2014
Pichler, M; Ress, AL; Winter, E; Stiegelbauer, V; Karbiener, M; Schwarzenbacher, D; Scheideler, M; Ivan, C; Jahn, SW; Kiesslich, T; Gerger, A; Bauernhofer, T; Calin, GA; Hoefler, G
MiR-200a regulates epithelial to mesenchymal transition-related gene expression and determines prognosis in colorectal cancer patients.
Br J Cancer. 2014; 110(6):1614-1621
Doi: 10.1038/bjc.2014.51
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Ress, AL; Stiegelbauer, V; Schwarzenbacher, D; Deutsch, A; Perakis, S; Ling, H; Ivan, C; Calin, GA; Rinner, B; Gerger, A; Pichler, M
Spinophilin expression determines cellular growth, cancer stemness and 5-flourouracil resistance in colorectal cancer.
Oncotarget. 2014; 5(18):8492-8502
Doi: 10.18632/oncotarget.2329
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Schimpel, C; Teubl, B; Absenger, M; Meindl, C; Fröhlich, E; Leitinger, G; Zimmer, A; Roblegg, E
Development of an advanced intestinal in vitro triple culture permeability model to study transport of nanoparticles.
Mol Pharm. 2014; 11(3):808-818
Doi: 10.1021/mp400507g
Web of Science
PubMed
FullText
FullText_MUG
2011
Millotti, G; Perera, G; Vigl, C; Pickl, K; Sinner, FM; Bernkop-Schnürch, A
The use of chitosan-6-mercaptonicotinic acid nanoparticles for oral peptide drug delivery.
Drug Deliv. 2011; 18(3): 190-197.
Doi: 10.3109/10717544.2010.522611
Web of Science
PubMed
FullText
FullText_MUG
Motta, JP; Magne, L; Descamps, D; Rolland, C; Squarzoni-Dale, C; Rousset, P; Martin, L; Cenac, N; Balloy, V; Huerre, M; Fröhlich, LF; Jenne, D; Wartelle, J; Belaaouaj, A; Mas, E; Vinel, JP; Alric, L; Chignard, M; Vergnolle, N; Sallenave, JM
Modifying the protease, antiprotease pattern by elafin overexpression protects mice from colitis.
Gastroenterology. 2011; 140(4): 1272-1282.
Doi: 10.1053/j.gastro.2010.12.050
Web of Science
PubMed
FullText
FullText_MUG
2010
Gorkiewicz, G; Kienesberger, S; Schober, C; Scheicher, SR; Gülly, C; Zechner, R; Zechner, EL
A genomic island defines subspecies-specific virulence features of the host-adapted pathogen Campylobacter fetus subsp. venerealis.
J Bacteriol. 2010; 192(2): 502-517.
Doi: 10.1128/JB.00803-09
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2009
Millotti, G; Samberger, C; Fröhlich, E; Bernkop-Schnürch, A
Chitosan-graft-6-mercaptonicotinic acid: synthesis, characterization, and biocompatibility.
Biomacromolecules. 2009; 10(11): 3023-3027.
Doi: 10.1021/bm9006248
Web of Science
PubMed
FullText
FullText_MUG
2008
Calayir, E; Becker, TM; Kratzer, A; Ebner, B; Panzenböck, U; Stefujl, J; Kostner, GM
LXR-agonists regulate ApoM expression differentially in liver and intestine.
Curr Pharm Biotechnol. 2008; 9(6): 516-521.
Doi: 10.2174/138920108786786376
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
2001
Jost, PJ; Harbottle, RP; Knight, A; Miller, AD; Coutelle, C; Schneider, H
A novel peptide, THALWHT, for the targeting of human airway epithelia.
FEBS Lett. 2001; 489(2-3):263-269
Doi: 10.1016/s0014-5793(00)02236-5
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG